小児ワクチン接種が薬剤耐性菌リスクを低減(Study links childhood vaccination to lower risk of drug-resistant bacteria)

ad

2025-12-02 ワシントン州立大学(WSU)

米 Washington State University(WSU)の研究によると、小児期に肺炎球菌などのワクチン接種を受けていた子どもは、薬剤耐性細菌を保有する率が低いことが分かった。研究はワクチン接種歴と細菌キャリア率を比較したもので、ワクチンを受けていない子どもに比べて、耐性菌の検出頻度が有意に低いという結果だった。ワクチンにより本来感染を防げる病原体の発症および治療に用いる抗菌薬の使用が減ることで、耐性菌の選択圧が低まり、抗菌薬耐性(AMR)の抑制につながる可能性がある。この知見は、ワクチン接種が個人の感染症防止にとどまらず、公衆衛生および耐性菌対策という観点でも強く有用であることを示しており、ワクチン普及と抗菌薬使用削減を同時に進める政策の必要性を支持する。

<関連情報>

グアテマラの小児における広域スペクトルセファロスポリン耐性腸内細菌科(ESCrE)の定着に対する肺炎球菌ワクチン(PCV13)とロタウイルスワクチン(RV)の効果の評価 Assessing effects of pneumococcal vaccination (PCV13) and rotavirus vaccination (RV) on colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in Guatemalan children

Brooke M. Ramay, Jonathan Yoder, Carmen Castillo, Natalie Fahsen, Laura Grajeda, Lucas F. Santos, Juan Carlos Romero, Maria Renee Lopez, Guy H. Palmer, Celia Cordon-Rosales, Douglas R. Call
Vaccine  Available online: 13 October 2025
DOI:https://doi.org/10.1016/j.vaccine.2025.127852

小児ワクチン接種が薬剤耐性菌リスクを低減(Study links childhood vaccination to lower risk of drug-resistant bacteria)

Abstract

Background

We aimed to determine if vaccination against rotavirus (RV) or pneumococcus (PCV13) is associated with reduced colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in children (<15 years) living in Guatemala.

Methods

Questionnaire information, vaccine records, and stool samples were collected from enrolled participants. Specimens were plated onto selective media with antibiotic susceptibility confirmed using a VITEK®2. We employed an instrumental variables approach with maximum likelihood for a system of three nested probit regression equations for binary outcomes of RV or PCV13 vaccination, diarrhea or clinic visits, and ESCrE colonization.

Results

Participants (n = 406) ranged from 0 to 14 years old, 123 (30.3 %) were 0–2 years old, 103 (25.4 %) were 3–5 years old, and 180 (44.3 %) were 6–14 years old. PCV13 vaccination had indirect negative effects on ESCrE colonization (-0.092, P < 0.01) mediated through clinic visits (-0.461, P < 0.01), while antibiotic use had a direct positive effect on clinic visits (0.226, P < 0.01), but no significant effects on ESCrE colonization. Effects of RV on ESCrE colonization were inconclusive likely due to the limited sample size of RV-unvaccinated children. Protective effects of yogurt consumption on ESCrE colonization (-0.064, P < 0.01; -0.062, P < 0.01) and positive direct effects of land used for agriculture (0.232, P < 0.01; 0.224, P 〈001) were detected in both RV and PCV13 models, respectively. Report of diarrhea in the past 30 days had a direct positive effect on colonization (0.731, P < 0.01) in the RV model, and indirect positive effects on ESCrE colonization (0.090, P < 0.01) in the PCV13 model.

Interpretation

Vaccination for pneumococcal disease was associated with a reduction in colonization with ESCrE bacteria. Antibiotic use did not contribute directly or indirectly to ESCrE colonization. These findings should be confirmed through studies designed to collect clinical outcomes data. Findings from this and other studies suggest that ESCrE colonization is mediated by a complex interplay of factors.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました